A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2001
12/20/2001	CA2411798A1 Serine protease inhibitors
12/20/2001	CA2411495A1 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
12/20/2001	CA2411116A1 Indole derivatives and their use as 15-lipoxygenase inhibitors
12/20/2001	CA2411036A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues
12/20/2001	CA2410824A1 Diamino phenothiazine derivatives and composition comprising same
12/20/2001	CA2410659A1 Transgenic mice containing nuclear hormone receptor gene disruptions
12/20/2001	CA2410610A1 Human kinases
12/20/2001	CA2410532A1 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
12/20/2001	CA2410228A1 A combination product comprising melagatran and a factor viia inhibitor
12/20/2001	CA2410171A1 Novel heterocyclic analogs of diphenylethylene compounds and uses thereof
12/20/2001	CA2410100A1 A combination product comprising melagatran and a factor xa inhibitor
12/20/2001	CA2409315A1 Protein phosphatases
12/20/2001	CA2407699A1 Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
12/19/2001	EP1164140A1 Novel sulfofucosylacylglycerol derivatives and utilization thereof as drugs
12/19/2001	EP1164139A1 Novel sulforhamnosylacylglycerol derivatives and utilization thereof as drugs
12/19/2001	EP1164136A1 Long wavelength absorbing bacteriochlorin alkyl ether analogs
12/19/2001	EP1164134A1 Benzimidazole compounds and their use as modulators of the GABA A receptor complex
12/19/2001	EP1163524A2 Methods of screening for colorectal cancer modulators
12/19/2001	EP1163373A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
12/19/2001	EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
12/19/2001	EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
12/19/2001	EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
12/19/2001	EP1163331A1 50 human secreted proteins
12/19/2001	EP1163262A1 Phenylalanine derivatives
12/19/2001	EP1163255A1 50 human secreted proteins
12/19/2001	EP1163254A2 Trpm-2 antisense therapy
12/19/2001	EP1163247A1 Pharmaceutical compositions comprising metal complexes
12/19/2001	EP1163246A1 Organic-arsenic compounds
12/19/2001	EP1163243A2 Calanolides for inhibiting btk
12/19/2001	EP1163238A1 Chemokine recpetor binding heterocyclic compounds
12/19/2001	EP1163237A1 Amide derivatives
12/19/2001	EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents
12/19/2001	EP1163233A1 Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use
12/19/2001	EP1163226A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
12/19/2001	EP1163225A1 Compounds and methods for modulation of estrogen receptors
12/19/2001	EP1163221A1 Sulfonamide derivatives as 5ht7 receptor antagonists
12/19/2001	EP1163220A1 Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
12/19/2001	EP1163219A1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
12/19/2001	EP1163213A1 Hydroxamic and carboxylic acid derivatives
12/19/2001	EP1163212A1 Amide derivatives
12/19/2001	EP1163208A2 Caspase inhibitors and uses thereof
12/19/2001	EP1163203A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt
12/19/2001	EP1163195A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
12/19/2001	EP1163029A2 Nitrate esters and their use for inducing neuroprotection and cognition enhancement
12/19/2001	EP1163024A1 Delivery of macromolecules into cells
12/19/2001	EP1163010A1 Hemoglobin-antioxidant conjugates
12/19/2001	EP1163005A1 Model and method for angiogenesis inhibition
12/19/2001	EP1162988A1 Wafer delivery system
12/19/2001	EP1162981A1 Treatment of accidental extravasation of anthracyclines
12/19/2001	EP1162980A2 Use of pyridoxine compounds for the treatment of cardiovascular and related pathologies
12/19/2001	EP1162979A2 Cyclic glycerophosphates and analogs thereof
12/19/2001	EP1162976A2 Regulation of phospholipase d activity
12/19/2001	EP1162974A1 Quinazoline formulations and therapeutic use thereof
12/19/2001	EP1162969A2 Compositions for improving fertility
12/19/2001	EP1162968A1 Use of epigallocatechin-gallate for inhibiting angiogenesis
12/19/2001	EP1162967A1 The use of certain affinity nmda antagonists as antidepressants
12/19/2001	EP1162964A1 Treatment of pulmonary hypertension
12/19/2001	EP1162961A2 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES
12/19/2001	EP1162960A2 Pharmaceutical compositions for the treatment of posttraumatic stress disorder
12/19/2001	EP1162959A2 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
12/19/2001	EP1162953A2 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances
12/19/2001	EP1162884A1 Oral low dose butyrate compositions
12/19/2001	EP1102592A4 Coumarin and related aromatic-based polymeric prodrugs
12/19/2001	EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/19/2001	EP1033978B1 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
12/19/2001	EP1014965A4 Dietary compositions for enhancing metabolism and alleviating oxidative stress
12/19/2001	EP0828742B1 Diazepino-indoles as phosphodiesterase iv inhibitors
12/19/2001	EP0813520B1 Arylsulfonylamino hydroxamic acid derivatives
12/19/2001	EP0785781B1 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation
12/19/2001	EP0766557B1 Topical compositions comprising n-acetyl-l-cysteine
12/19/2001	EP0707849B1 Use of derivatives of 2,4-disubstituted phenols as 5-lipoxigenase inhibitors
12/19/2001	CN1327452A Fibroblast growth factor with hepatocyte proliferation activity
12/19/2001	CN1327444A Alpha 1 beta-adrenergic receptor antagonists
12/19/2001	CN1327443A Substituted anilides
12/19/2001	CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/19/2001	CN1326928A Biphenyl sulfonyl amino-cyanogen, its preparing method and use as medicine thereof
12/19/2001	CN1326765A 抗疲劳的药物 Anti-fatigue drug
12/19/2001	CN1326758A Medicine for curing shaoyang disease and its preparing method
12/19/2001	CN1326752A Medicine for curing apocrine sweat gland hircus
12/19/2001	CN1076356C Protein having TPO activity
12/19/2001	CN1076353C Alkyl boronic acid derivatives, process for their preparation and pharmaceutical compositions containing them
12/19/2001	CN1076352C 5-(2-imidazolinylamino) benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agaonists
12/19/2001	CN1076202C Prescription of tonglufutanwan as medicine for activating collaterals and rehabilitating paralysis
12/19/2001	CN1076199C Clear-heading agent and its prepn. method
12/19/2001	CN1076196C Pharmaceutical composition
12/18/2001	US6331637 N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
12/18/2001	US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control
12/18/2001	US6331631 Reacting 4-piperidinocarboxamide and 1-bromobutane, reduction with lithium aluminum hydride using toluene as solvent
12/18/2001	US6331623 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
12/18/2001	US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand)
12/18/2001	US6331612 Bone morphogenic protein-16 (BMP-16) compositions
12/18/2001	US6331571 Methods of treating and preventing attention deficit disorders
12/18/2001	US6331570 Active enantiomer of RARγ-specific agonist
12/18/2001	US6331564 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
12/18/2001	US6331560 Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticals
12/18/2001	US6331559 Lipoic acid derivatives and their use in treatment of disease
12/18/2001	US6331556 Benzofuran-4-carboxylic acid amide derivatives used as phosphodiesterase iv or tumor necrosis factor inhibitors
12/18/2001	US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders
12/18/2001	US6331542 Protease inhibitors
12/18/2001	US6331536 Administering to patient in need thereof effective amount of serotonin receptor antagonist to prevent or ameliorate sleep-related breathing disorder

1 ... 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 ... 1564